May 10, 2012
Shionogi & Co. announced on May 9 that its US subsidiary, Shionogi Inc., submitted a new drug application (NDA) to the US FDA for ospemifene 60 mg tablets for the treatment of postmenopausal vulvar and vaginal atrophy (VVA) on April...read more